See also this year's filing and all EDGAR filings for this company.
PDF Report 0001260990_2017_Oncternal_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001260990')"} |
Graph
Absolute values for 0001260990, Oncternal Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 24,298,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 123,000 |
| 2 | PropertyPlantAndEquipmentNet | 81,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 4,611,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,705,000 |
| 9 | ResearchAndDevelopmentExpense | 17,228,000 |
| 10 | remainder_Expenses | -8,163,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 46,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 24,502,000 |
| 1 | Liabilities | 4,611,000 |
| 2 | Expenses | 17,770,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 19,891,000 |
| 5 | NetIncome | -17,724,000 |
| 6 | ComprehensiveNetIncome | -17,724,000 |
| 7 | BaseVar | 23,464,500 |
| 8 | EconomicCapitalRatio | 1.13 |
Edgar->Model Mapping
Feature Distribution
